| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |